You are here

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia A, Hemophilia B
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- The study population will consist of all patients diagnosed with hemophilia (D66.9
(hemophilia A) D67.9 (hemophilia B) in International Statistical Classification of
Diseases and Related Health Problems (ICD-10) that have been registered in the Malmö
Hemophilia Register since 1977 and that have had at least one registered prescription
of BeneFIX or ReFacto/ReFacto AF in the MHR since market authorization of the
respective product

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- No exclusion criteria in this study

NCT02740413
Pfizer
Completed
Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Hemophilia A
NCT00168051
Males
18+
Years
Multiple Sites
Hemophilia B
NCT00714415
All Genders
0+
Years
Multiple Sites
HEMOPHILIA B
NCT02336178
All Genders
0+
Years
Multiple Sites
Hemophilia A
NCT00895037
All Genders
0+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now